These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 19874422)
1. Serially heterotransplanted human prostate tumours as an experimental model. Lopez-Barcons LA J Cell Mol Med; 2010 Jun; 14(6B):1385-95. PubMed ID: 19874422 [TBL] [Abstract][Full Text] [Related]
2. Human prostate cancer heterotransplants: a review on this experimental model. Lopez-Barcons LA Asian J Androl; 2010 Jul; 12(4):509-18. PubMed ID: 20364154 [TBL] [Abstract][Full Text] [Related]
3. Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model? Lopez-Barcons LA Asian J Androl; 2010 May; 12(3):308-14. PubMed ID: 20023690 [TBL] [Abstract][Full Text] [Related]
4. Human benign prostatic hyperplasia heterotransplants as an experimental model. Lopez-Barcons LA Asian J Androl; 2010 Mar; 12(2):157-63. PubMed ID: 19946317 [TBL] [Abstract][Full Text] [Related]
5. An original patient-derived xenograft of prostate cancer with cyst formation. Yoshikawa T; Kobori G; Goto T; Akamatsu S; Terada N; Kobayashi T; Tanaka Y; Jung G; Kamba T; Ogawa O; Inoue T Prostate; 2016 Aug; 76(11):994-1003. PubMed ID: 27098584 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of peptide-based imaging agents [ Zhang-Yin J; Provost C; Cancel-Tassin G; Rusu T; Penent M; Radulescu C; Comperat E; Cussenot O; Montravers F; Renard-Penna R; Talbot JN; Prignon A Nucl Med Biol; 2020; 84-85():88-95. PubMed ID: 32251995 [TBL] [Abstract][Full Text] [Related]
7. Establishing prostate cancer patient derived xenografts: lessons learned from older studies. Russell PJ; Russell P; Rudduck C; Tse BW; Williams ED; Raghavan D Prostate; 2015 May; 75(6):628-36. PubMed ID: 25560784 [TBL] [Abstract][Full Text] [Related]
8. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models. Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676 [TBL] [Abstract][Full Text] [Related]
10. Development of seven new human prostate tumor xenograft models and their histopathological characterization. van Weerden WM; de Ridder CM; Verdaasdonk CL; Romijn JC; van der Kwast TH; Schröder FH; van Steenbrugge GJ Am J Pathol; 1996 Sep; 149(3):1055-62. PubMed ID: 8780407 [TBL] [Abstract][Full Text] [Related]
11. Heterotransplantation of human head and neck tumours into nude mice. Wennerberg J; Tropé C; Biörklund A Acta Otolaryngol; 1983; 95(1-2):183-90. PubMed ID: 6829300 [TBL] [Abstract][Full Text] [Related]
12. Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice. Hoehn W; Wagner M; Riemann JF; Hermanek P; Williams E; Walther R; Schrueffer R Prostate; 1984; 5(4):445-52. PubMed ID: 6739375 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR. Engehausen DG; Krause FS; Fleischmann J; Akcetin Z; Schrott KM; Endele S Anticancer Res; 2005; 25(3A):1611-4. PubMed ID: 16033069 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone. Jungwirth A; Schally AV; Pinski J; Halmos G; Groot K; Armatis P; Vadillo-Buenfil M Br J Cancer; 1997; 75(11):1585-92. PubMed ID: 9184172 [TBL] [Abstract][Full Text] [Related]
16. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555 [TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
18. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models. Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223 [TBL] [Abstract][Full Text] [Related]
19. Development of a castrate resistant transplant tumor model of prostate cancer. Ellis L; Lehet K; Ramakrishnan S; Adelaiye R; Pili R Prostate; 2012 May; 72(6):587-91. PubMed ID: 21796655 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity. Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]